Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-11

Clinical Trial Update: Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus [Phase 3]

View source ↗

Summary

Phase 3 trial comparing lorazepam, clonazepam, and clonazepam plus fosphenytoin for out-of-hospital generalized status epilepticus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonazepam (Clonazepam)
  • Lorazepam (Lorazepam)
  • fosphenytoin (fosphenytoin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Status Epilepticus, Epilepsy | Phase 3 | Status: COMPLETED